Envestnet Asset Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Envestnet Asset Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-19,173	Closed	-$808K	–	4193
2023 Q2	$808K	Sell	19,173 -375,863	-95%	-$15.2M	﹤0.01%	2904
2023 Q1	$7.38M	Buy	395,036 +238,665	+153%	+$8.66M	﹤0.01%	1418
2022 Q4	$5.74M	Sell	156,371 -62,066	-28%	-$2.45M	﹤0.01%	1519
2022 Q3	$10.3M	Sell	218,437 -1,340	-0.6%	-$86.5K	0.01%	1114
2022 Q2	$15.8M	Buy	219,777 +14,213	+7%	+$1.04M	0.01%	910
2022 Q1	$16.6M	Sell	205,564 -103,497	-33%	-$8.76M	0.01%	937
2021 Q4	$31.7M	Sell	309,061 -1,328	-0.4%	-$128K	0.02%	653
2021 Q3	$27.2M	Buy	310,389 +57,263	+23%	+$5.18M	0.01%	670
2021 Q2	$22.7M	Buy	253,126 +82,730	+49%	+$6.99M	0.01%	733
2021 Q1	$12.9M	Buy	170,396 +18,381	+12%	+$1.39M	0.01%	904
2020 Q4	$10.4M	Buy	152,015 +25,587	+20%	+$1.6M	0.01%	899
2020 Q3	$6.72M	Buy	126,428 +11,735	+10%	+$699K	0.01%	1001
2020 Q2	$6.68M	Buy	114,693 +42,373	+59%	+$2.28M	0.01%	970
2020 Q1	$2.85M	Buy	72,320 +5,290	+8%	+$309K	﹤0.01%	1254
2019 Q4	$3.99M	Buy	67,030 +7,038	+12%	+$378K	﹤0.01%	1253
2019 Q3	$3.19M	Buy	59,992 +5,278	+10%	+$271K	﹤0.01%	1290
2019 Q2	$2.79M	Sell	54,714 -1,815	-3%	-$84.5K	﹤0.01%	1360
2019 Q1	$2.93M	Buy	56,529 +9,456	+20%	+$458K	﹤0.01%	1285
2018 Q4	$1.85M	Buy	+47,073	New	+$2.19M	﹤0.01%	1386
2018 Q3	–	Sell	-3,333	Closed	-$156K	–	2775
2018 Q2	$156K	Sell	3,333 -71	-2%	-$2.94K	﹤0.01%	1791
2018 Q1	$124K	Buy	+3,404	New	+$133K	﹤0.01%	1828
2017 Q4	–	Sell	-387	Closed	-$21K	–	3016
2017 Q3	$21K	Sell	387 -831	-68%	-$46.3K	﹤0.01%	2488
2017 Q2	$71K	Sell	1,218 -721	-37%	-$37.5K	﹤0.01%	2249
2017 Q1	$87K	Sell	1,939 -127	-6%	-$6.32K	﹤0.01%	2233
2016 Q4	$109K	Buy	+2,066	New	+$100K	﹤0.01%	2153
2016 Q3	–	Sell	-1,957	Closed	-$75K	–	3095
2016 Q2	$75K	Buy	1,957 +29	+2%	+$1.27K	﹤0.01%	2562
2016 Q1	$79K	Buy	+1,928	New	+$79.5K	﹤0.01%	2517

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Envestnet Asset Management's SYNH Position: Q3 2023 in Review

Envestnet Asset Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 19,173 shares — an estimated $808K sold.

Envestnet Asset Management first reported a position in SYNH in Q1 2016 and held it in 27 quarters. The position peaked at $31.7M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Envestnet Asset Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Envestnet Asset Management sold 19,173 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $808K.
Envestnet Asset Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2016 and held it in 27 quarters.
Envestnet Asset Management's Syneos Health, Inc. Class A Common Stock position peaked at $31.7M in Q4 2021.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Envestnet Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.